Tirzepatide Dosage Calculator: How Your Dose Progression Really Works

Step 1: why every prescription starts at 2.5 mg

The licensed titration schedule begins at 2.5 mg for the first four weeks. This is not a weight-loss dose in any meaningful sense, it exists because tirzepatide activates two gut-hormone receptors simultaneously (GIP and GLP-1), and your digestive system needs time to adapt. Starting low sharply reduces the nausea, vomiting and constipation that are most common in the opening weeks. The NHS patient information for tirzepatide explains this tolerability rationale clearly.

Some people find 2.5 mg produces noticeable appetite suppression from the first week; others feel little change. Both experiences are normal. What matters at this stage is settling in, not the number on the scale. A prescriber who reviews you after four weeks is checking that you have tolerated the dose well, that assessment is what unlocks the move to 5 mg.

Plenty of online tools will show you a bar chart of the six dose levels and call it a tirzepatide dosage calculator for weight loss. What they cannot show is whether your specific side-effect profile, or a health condition in your history, means your prescriber will take a slower path. The schedule is a framework; your experience is the variable.

Step 2: progressing through 5 mg to the maintenance zone

After 2.5 mg, doses typically step up in four-week intervals: 5 mg, then 7.5 mg, then 10 mg, 12.5 mg and finally 15 mg. Each step is a clinical decision, not an automatic increment. If a particular dose is causing difficult side effects, a prescriber may pause titration at that level for an additional four weeks rather than pushing upward. That is entirely normal practice and does not mean treatment has stalled.

The largest weight-loss effects in SURMOUNT-1 (involving 2,539 adults with obesity) were seen at 10 mg and 15 mg, with average body-weight reductions of around 20–21% at 15 mg over 72 weeks, as published in the New England Journal of Medicine. Many people find a dose that suits them before reaching 15 mg, and NICE's guidance on tirzepatide (TA1026) notes that treatment should be reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose.

If you want to understand what the 5 mg step looks like in practice (including what to expect from that specific pen) our 5 mg dosage guide covers that stage in detail. Similarly, the 10 mg page is worth reading once you approach the mid-range doses.

Step 3: how a prescriber makes the call at each review

This is where the gap between a dosage calculator and an actual clinical review is sharpest. A prescriber considers several things simultaneously: how much weight you have lost since the last step, whether side effects have settled or are still disruptive, whether any new symptoms have appeared that need investigation, and whether your starting conditions (blood pressure, blood-sugar control and similar factors) have changed.

At nume, a named prescriber reads your consultation answers the same day, not a template-matching algorithm. Dose increases require evidence of your current treatment, including recent weight. That structure exists because moving too quickly through the schedule when GI side effects are still significant is uncomfortable and often counterproductive; moving too slowly when someone has fully adjusted and needs more appetite suppression wastes time. The prescriber's judgement is what a calculator genuinely cannot replicate.

If you want a fuller breakdown of the overall dose schedule before your consultation, our tirzepatide dosage overview lays out the published progression clearly. For context on how cost varies by dose, our Mounjaro cost guide covers what private treatment typically looks like at different stages. It's worth reading that before your first review appointment, a question our prescribers hear most weeks is why prices differ between pen strengths.

What to do if you think your dose needs changing

If you are already on tirzepatide and feel your current dose is not working as well as it was, or side effects are making it hard to continue, the right step is to contact your prescribing team, not to search for a tirzepatide peptide dosage calculator online. Adjusting your own dose, skipping a pen to try a different strength, or ordering a different strength without a new clinical review are each a significant patient-safety risk.

The Patient Information Leaflet in your Mounjaro box details what to do if you miss a dose and gives storage guidance. For anything beyond that, your prescriber is the right person to speak to. You can also read our guide on how tirzepatide doses are calculated if you want a more detailed explanation of the clinical reasoning behind each step, or our Mounjaro overview for the broader picture of how this treatment works.

When you are ready to start, our free consultation connects you with a GPhC-registered prescriber who will work through your full history and set the right starting plan with you.